Showing 1 posts of 1 posts found.
US clinical-stage biopharmaceutical company Kymera Therapeutics has shared newย data regarding its oncology programmes KT-333 and KT-413, highlighting their robust dose-dependent …
Capital Dynamics invests โฌ14m in Italian community healthcare platform CareHub
Medtronic secures CE Mark for new cardiac pacing portfolio
Dermatology leader Doncker is new Onicor CEO
East London pharmacies pilot cholesterol-lowering injections to cut waiting times
Weber is new CMO at Sensorion